Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicola Fenderico
Observed names:
N Fenderico,
N. Fenderico
Institution:
Novartis (Italy)
Observed institutions:
University Medical Center Utrecht,
Pfizer (Switzerland),
Oncode Institute,
Institute for Research in Biomedicine,
Barcelona Institute of Science and Technology,
Novartis (Italy),
Fondazione IRCCS Istituto Nazionale dei Tumori
show all 7
ORCID:
0000-0003-3599-7931
Observed ORCID:
0000-0003-3599-7931
OpenAlex ID:
A5029743412
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
2020
·
Jeroen M. Bugter
, Nicola Fenderico
, et al.
·
Nature reviews. Cancer
·
478
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
2022
·
Adrià Cañellas-Socias
, Carme Cortina
, et al.
·
Nature
·
265
Wnt Signaling in 3D: Recent Advances in the Applications of Intestinal Organoids
2019
·
Alessandra Merenda
, Nicola Fenderico
, et al.
·
Trends in Cell Biology
·
117
PDF
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis
2017
·
Rihan El Bezawy
, Denis Cominetti
, et al.
·
Cancer Letters
·
98
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development
2012
·
P Gandellini
, V Profumo
, et al.
·
Cell Death and Differentiation
·
91
PDF
Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells
2019
·
Nicola Fenderico
, Revina C. van Scherpenzeel
, et al.
·
Nature Communications
·
67
PDF
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation
2019
·
Valentina Profumo
, Barbara Forte
, et al.
·
Nature Communications
·
53
PDF
TMEM59 potentiates Wnt signaling by promoting signalosome formation
2018
·
Jan P. Gerlach
, Ingrid Jordens
, et al.
·
Proceedings of the National Academy of Sciences
·
48
PDF
RNF43 truncations trap CK1 to drive niche‐independent self‐renewal in cancer
2020
·
Maureen Spit
, Nicola Fenderico
, et al.
·
The EMBO Journal
·
44
Publisher Correction: Mutations and mechanisms of WNT pathway tumour suppressors in cancer
2020
·
Jeroen M. Bugter
, Nicola Fenderico
, et al.
·
Nature reviews. Cancer
·
19
PDF
Three-dimensional analysis of single molecule FISH in human colon organoids
2019
·
Manja Omerzu
, Nicola Fenderico
, et al.
·
Biology Open
·
15
PDF
MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets
2013
·
Nicola Fenderico
, Anna Casamichele
, et al.
·
Current Medicinal Chemistry
·
14
BRAFV600E maintains the CpG island methylator phenotype, and DNA methylation of PRC2 targets genes in colon cancer
2025
·
Layla El Bouazzaoui
, Jeroen M. Bugter
, et al.
·
iScience
·
6
PDF
Mutation-induced phenotypic plasticity drives formation of a pro-metastatic tumour-intrinsic niche
2022
·
Jeroen M. Bugter
, Layla El Bouazzaoui
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
6
PDF
BRAFV600E augments WNT signaling in colorectal cancer via aberrant DNA methylation
2025
·
Layla El Bouazzaoui
, Jeroen M. Bugter
, et al.
·
iScience
·
4
PDF
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial
2022
·
Roberta Caputo
, Alessandra Fabi
, et al.
·
Breast Cancer Targets and Therapy
·
4
PDF
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial
2026
·
Giampaolo Bianchini
, Luca Malorni
, et al.
·
Clinical Cancer Research
·
3
PDF
Collaborative Funding Model to Improve Quality of Care for Metastatic Breast Cancer in Europe
2025
·
Matti S. Aapro
, Jacqueline Waldrop
, et al.
·
Current Oncology
·
1
PDF
Abstract B003: BRAFV600E is essential for maintenance of the CpG island methylator phenotype and DNA methylation of PRC2 target genes in colon cancer
2025
·
Layla El Bouazzaoui
, Jeroen M Bugter
, et al.
·
Cancer Research
·
1
199P Correlation of circulating tumor DNA (ctDNA) or thymidine kinase activity (TKa) dynamic patterns with tumor response in patients (pts) with hormone receptor (HR)+ human epidermal growth factor 2 (HER2)– advanced breast cancer (ABC) on ribociclib (RIB) + letrozole (LET) in BioItaLEE trial
2023
·
G. Arpino
, G. Bianchini
, et al.
·
ESMO Open
·
1
PDF
Abstract A134: MiR-875-5p impairs prostate cancer metastasis by remodeling tumor secretome and enhances tumor radiation response via EGFR suppression
2015
·
Nicola Fenderico
, Denis Cominetti
, et al.
·
Molecular Cancer Therapeutics
·
1
Supplementary Methods S1 from Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial
2026
·
Giampaolo Bianchini
, Luca Malorni
, et al.
Supplementary Figure S1 from Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial
2026
·
Giampaolo Bianchini
, Luca Malorni
, et al.
Supplementary Figure S3 from Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial
2026
·
Giampaolo Bianchini
, Luca Malorni
, et al.
Supplementary Figure S2 from Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial
2026
·
Giampaolo Bianchini
, Luca Malorni
, et al.
Show more works
View as search
Works count:
33
Citation count:
1,336
H-index:
12
I10-index:
12
Year
Topic
Type
